Trademark: 79339423
Word
SVARLA
Status
Registered
Status Code
700
Status Date
Tuesday, October 25, 2022
Serial Number
79339423
Registration Number
6882149
Registration Date
Tuesday, October 25, 2022
Mark Type
4000
Filing Date
Thursday, March 10, 2022
Published for Opposition
Tuesday, August 9, 2022

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The wording ¿SVARLA¿ has no meaning in a foreign language.

Trademark Events
Mar 14, 2023
Final Decision Transaction Processed By Ib
Feb 18, 2023
Final Disposition Notice Sent To Ib
Feb 17, 2023
Final Disposition Processed
Jan 25, 2023
Final Disposition Notice Created, To Be Sent To Ib
Oct 25, 2022
Notice Of Registration Confirmation Emailed
Oct 25, 2022
Registered-Principal Register
Aug 9, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Published For Opposition
Aug 8, 2022
Refusal Processed By Ib
Jul 20, 2022
Notification Of Notice Of Publication E-Mailed
Jul 13, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 13, 2022
Refusal Processed By Mpu
Jul 7, 2022
Approved For Pub - Principal Register
Jul 7, 2022
Examiner's Amendment Entered
Jul 7, 2022
Notification Of Examiners Amendment E-Mailed
Jul 7, 2022
Examiners Amendment E-Mailed
Jul 7, 2022
Examiners Amendment -Written
Jul 7, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 6, 2022
Notification Of Priority Action E-Mailed
Jul 6, 2022
Priority Action E-Mailed
Jul 6, 2022
Priority Action Written
Jul 5, 2022
Assigned To Examiner
Jun 20, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 20, 2022
Teas Change Of Correspondence Received
Jun 20, 2022
Teas Change Of Domestic Representatives Address
Jun 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 20, 2022
Teas Change Of Owner Address Received
May 17, 2022
Application Filing Receipt Mailed
May 11, 2022
New Application Office Supplied Data Entered
May 10, 2022
Limitation From Original Application Entered
Apr 28, 2022
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24